Osteoporosis is a condition in which bone mineral density is reduced. Low bone mass can lead to bone weakness and result in an increased risk of fractures, especially of the hip, spine, and forearm (Dow, 2006).
Women with breast cancer are at higher risk for developing osteoporosis as a result of chemotherapy effects and antiestrogen medication side effects. Estrogen usually provides bone protection.
Aromatase Inhibitors have been associated with an increased risk of bone loss. The incidence of osteoporosis among women in general has increased in the United States, therefore placing more women at increased risk at the time of their breast cancer diagnosis.
Managing risk, screening, and the early detection of osteoporosis is extremely important in the prevention of fractures.
For More Information